Sign for Notice Everyday    Sign Up| Sign In| Link| English|

Our Sponsors

    Receive Latest News

    Feedburner
    Share Us


    3-Hour Virtual Seminar on FDA's Scrutiny of Social Media Promotion

    View: 222

    Website www.traininng.com/webinar/3-hour-virtual-seminar-on-fda's-scrutiny-of-social-media-promotion--200598 | Want to Edit it Edit Freely

    Category Regulatory Directors, Marketing Directors, Quality Systems Auditors, Recall Managers

    Deadline: March 11, 2019 | Date: March 12, 2019

    Venue/Country: Online, U.S.A

    Updated: 2019-01-31 18:18:58 (GMT+9)

    Call For Papers - CFP

    Overview

    FDA steadily expands the scope and restrictions for promotion of products under its jurisdiction. Whatever and where ever to want to talk about your product, just assume your talking to FDA.

    Trolling for off-label information in social media, scrutiny of educational material under "safe harbor" and apparent conflicts of interest at a public event create a sink hole for firms even though it may seem innocent in your eyes.

    Facebook, Twitter or chat rooms can be rampant with off-label information. You even may be surprised about what people are saying about your product. Does FDA hold you accountable?

    Why should you Attend

    Limitations on commercial free speech

    Avenues of off-label information

    Working in a "safe harbor" for off-label information distribution

    Social media and your regulatory responsibilities

    Correcting off-label information

    Factoring in cognitive psychology

    Areas Covered in the Session

    Learn to navigate through FDA requirements

    Understand that your right to free speech is limited

    How to get around FDA prohibitions

    Ways to manage your presence in social media

    How to identify an off-label problem and corrective action

    Under how FDA applies cognitive psychology principles

    Who Will Benefit

    Regulatory Directors

    Marketing Directors

    Quality Systems Auditors

    Recall Managers

    In-house Legal Counsel

    Customer Support Staff

    Sales Staff

    Speaker Profile

    Casper (Cap) Uldriks through his firm "Encore Insight LLC," brings over 32 years of experience from the FDA. He specialized in the FDA's medical device program as a field investigator, served as a senior manager in the Office of Compliance and an Associate Center Director for the Center for Devices and Radiological Health. He developed enforcement actions and participated in the implementation of new statutory requirements. His comments are candid, straightforward and of practical value.


    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.